Securities

  • January 16, 2026

    OCC's Gould Takes Aim At Resolution Planning 'Industry'

    A top federal regulator called Friday for a sweeping rethink of rules intended to ensure big, complex banks can be safely wound down in a crisis, including potentially ending requirements to file so-called living wills with the Federal Deposit Insurance Corp.

  • January 16, 2026

    Stock Buyback Ban Could Shrink Defense Industrial Base

    The Trump administration's move to bar defense contractors from buying back their stock or paying shareholder dividends if they are underperforming on their contracts could make companies reconsider working with the U.S. government and counteract the administration's stated goals.

  • January 16, 2026

    SEC Secures $39M Orders Wrapping Fla. Investor Fraud Suit

    The U.S. Securities and Exchange Commission has gotten final judgments totaling nearly $39 million to wrap up claims that a Florida hedge fund manager, associated entities and their owner defrauded would-be investors by concealing self-dealing and misappropriation.

  • January 16, 2026

    SEC Fines Biopharma Co. Execs Over Hidden FDA Findings

    Former executives of Spero Therapeutics will pay over $187,000 to settle the U.S. Securities and Exchange Commission's claims they downplayed the likelihood that the U.S. Food and Drug Administration would reject the biopharmaceutical company's new drug application in 2022, the commission said on Friday.

  • January 16, 2026

    SEC Fines 'Cash Flow King' Podcaster $3M For Ponzi Scheme

    A podcast host dubbed the "Cash Flow King" will pay $3.3 million to settle claims that he ran a multiyear Ponzi scheme that cheated investors out of $11 million through bogus real estate investments, the U.S. Securities and Exchange Commission announced Friday.

  • January 16, 2026

    Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit

    Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to remain compliant with Nasdaq listing requirements and causing share declines.

  • January 16, 2026

    6th Circ. Revives Biomed Co. Investor's Suit Over Stock Sale

    The Sixth Circuit has ruled that a man who sold his stock in a biomedical research company just before being told the company planned to pursue private equity financing can bring his breach of contract and fiduciary duty claims, reversing a lower court's ruling granting summary judgment to the biomedical company.

  • January 16, 2026

    $29M Deal In Boeing Supplier Fraud Suit Gets Final OK

    A New York federal judge on Friday approved a $29 million deal to close out a suit alleging that Spirit AeroSystems Holdings Inc. misled investors by failing to disclose pervasive quality problems and a documented history of supplying its chief customer, The Boeing Co., with defective plane parts.

  • January 16, 2026

    SIFMA Presses SEC To Reverse Nasdaq Fee Hike

    The Securities Industry and Financial Markets Association is urging the U.S. Securities and Exchange Commission to force Nasdaq and other exchanges to stop collecting new fees that the organization argues were allowed to go live with little detail as to why they were necessary or how they comply with the law and past SEC guidance.

  • January 16, 2026

    Acadia Investors Get Initial OK For $179M Settlement

    Acadia Healthcare Co. Inc. investors have received the first OK from a Tennessee federal judge for a $179 million settlement in a class action alleging the company misled them about the strength of its U.K. operations.

  • January 16, 2026

    Pomerantz To Lead Biohaven Investors' FDA Approval Suit

    Pomerantz LLP will lead a proposed class of investors accusing biopharmaceutical company Biohaven Ltd. of overstating the odds that two of its product candidates would receive regulatory approval, a Connecticut judge said Friday.

  • January 16, 2026

    Judge Yanks $41M Atty Fee Award In SPAC Merger Suit

    A Texas federal judge has rescinded an attorney fee award of over $41 million to Robbins Geller Rudman & Dowd LLP, Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP after the firms became engaged in a dispute over the amount of work done and the allocation of fees, among other things.

  • January 16, 2026

    7th Circ. Won't Revive Investment Cos.' VIX-Fix Claims

    The Seventh Circuit on Thursday affirmed the dismissal of two investment companies' volatility index manipulation claims against Barclays, Morgan & Stanley Co. and other financial institutions, agreeing with a lower court that one lacked standing and the other missed a statutory deadline.

  • January 16, 2026

    High Court Takes Up Intel Workers' Bid To Revive 401(k) Suit

    The U.S. Supreme Court agreed Friday to hear Intel workers' challenge to a Ninth Circuit decision backing an end to their proposed class action alleging 401(k) mismanagement, a case that gives the justices a chance to clarify the pleading standards for retirement fund underperformance. 

  • January 16, 2026

    Insurer Says Other Carrier Owes $23M For Old Policy Claims

    Sparta Insurance Co. said the former parent of an insurer it acquired reneged on its contractual obligations to handle and pay claims under policies issued before the acquisition, telling a Massachusetts federal court that it is owed more than $23 million in settlement payments, attorney fees and other costs.

  • January 15, 2026

    NCAA Urges Feds, States To Rein In College Sports Wagers

    The NCAA has urged a federal regulator to suspend prediction market trades based on college sports until appropriate safeguards are in place and called on state gambling commissions to restrict certain types of wagers, saying it knows they are being manipulated.

  • January 15, 2026

    SEC Says Healthcare Exec Misspent $10.6M In Investor Funds

    The U.S. Securities and Exchange Commission on Thursday accused a healthcare company CEO of misappropriating over $10 million from investors by falsely claiming the funds would be used to develop cancer screening and treatment technology when in fact they were spent on credit card debt, luxury vehicles and strip club visits.

  • January 15, 2026

    Getty Loses 2nd Circ. Bid Over $88M Stock Sale Breach Order

    A divided Second Circuit on Thursday upheld a ruling requiring Getty Images to pay out nearly $88 million to investors who said they were blocked from purchasing shares in the company once it became public, finding Getty breached a contract promising the investors those shares.

  • January 15, 2026

    Musk Slams SEC's 'Premature' Bid For Twitter Buy-Up Win

    The U.S. Securities and Exchange Commission shouldn't be handed an early win on its claims Elon Musk didn't make timely disclosures of his stake in Twitter when the regulator hasn't yet produced discovery in the matter, the tech billionaire has argued.

  • January 15, 2026

    Dechert Adds Ex-NYC Deputy Mayor To Co-Lead Trial Practice

    Dechert LLP announced Thursday that it has hired veteran trial lawyer Randy Mastro, who previously served as former New York City Mayor Eric Adams' first deputy, as a partner and co-chair of the firm's securities and complex litigation practice.

  • January 15, 2026

    Ex-CEO Of COVID Vax Maker Accused Of Insider Trading

    New York Attorney General Letitia James on Thursday sued the former CEO of healthcare contractor Emergent BioSolutions Inc., alleging insider trading amid troubles manufacturing a COVID-19 vaccine, while signing a $900,000 settlement with the company over its approval of an executive trading plan.

  • January 15, 2026

    Dems Push SEC To Pursue Crypto Case Against Justin Sun

    Three House Democrats on Thursday pressed the U.S. Securities and Exchange Commission to reinvigorate its paused enforcement case against Tron founder Justin Sun and address their concerns that the agency's wave of crypto case dismissals coincided with considerable industry donations to President Donald Trump.

  • January 15, 2026

    Chancery Tosses Vividion IP Suit Over $2B Bayer Deal

    The Delaware Chancery Court on Thursday dismissed a biotech investor's suit accusing the co-founder of Vividion Therapeutics Inc. and others of diverting valuable intellectual property ahead of the company's $2 billion sale to Bayer Corp., finding the alleged misconduct could not have affected the merger price or process under Delaware law.

  • January 15, 2026

    Nvidia Sued In Del. For US 'Tax' On Chip Deal With China

    Alleging possible company conflicts of interest and unlawful agreements involving the White House and Commerce Department, two NVIDIA Corp. stockholders sued the company late Wednesday for records involving company agreements to pay the U.S. Department of Commerce percentages of high-end graphics processing chip sales to buyers in China.

  • January 15, 2026

    Crypto Lender Nexo Fined $500K For Unlicensed Loans

    The California Department of Financial Protection and Innovation announced that crypto-backed loan company Nexo Capital Inc. will pay a $500,000 penalty to settle claims it did not have a valid license when making its high-risk loans to California residents.

Expert Analysis

  • Assessing The SEC's Changing Approach To NFT Regulation

    Author Photo

    Early U.S. Securities and Exchange Commission actions on nonfungible tokens pushed for broad regulation, but subsequent court decisions — including a recent California federal court ruling in Adonis Real v. Yuga Labs — and SEC commissioners' statements have narrowed the regulatory focus toward a more fact-specific approach, say attorneys at Wilson Elser.

  • Where Crypto Mixing Enforcement Is Headed From Here

    Author Photo

    Recent developments involving crypto mixers, particularly the Tornado Cash verdict, demonstrate that the Justice Department's shift away from regulation by prosecution does not mean total immunity, rather reflecting an approach that prioritizes both innovation and accountability, says David Tarras at Tarras Defense.

  • Why Foreign Cos. Should Prep For Increased SEC Oversight

    Author Photo

    With the recent trading suspensions of 10 foreign-based issuers listed on the Nasdaq, an enforcement action against a U.K. security-based swap dealer and the announcement of a cross-border task force, it's clear that the U.S. Securities and Exchange Commission will expand oversight on foreign companies participating in the U.S. capital markets, says Tejal Shah at Cooley.

  • What Narrower FinCEN Reporting Spells For Industry

    Author Photo

    As compliance costs soar, the potential slimming down of the Financial Crimes Enforcement Network's anti-money laundering and countering the financing of terrorism regime is welcome news for banks, and would allow a shift in resources to ever-evolving cybercrime threats, say attorneys at Quarles & Brady.

  • Revisiting Jury Trial Right May Upend State Regulatory Power

    Author Photo

    Justice Neil Gorsuch’s recent use of a denial of certiorari to call for the U.S. Supreme Court to revisit whether the Seventh Amendment jury trial right extends to states, building off last year's Jarkesy ruling, could foretell a profound change in state regulators' ability to enforce penalties against regulated companies, say attorneys at Sidley.

  • How Nasdaq, SEC Proposals May Transform Listing Standards

    Author Photo

    Both Nasdaq and the U.S. Securities and Exchange Commission have increasingly focused their recent regulatory efforts on small and foreign issuers, particularly those from China, reflecting an intention to strengthen the overall quality of companies accessing U.S. markets, but also potentially introducing a chilling effect on certain issuers, say attorneys at Norton Rose.

  • Series

    Building With Lego Makes Me A Better Lawyer

    Author Photo

    Building with Lego has taught me to follow directions and adapt to unexpected challenges, and in pairing discipline with imagination, allows me to stay grounded while finding new ways to make complex deals come together, says Paul Levin at Venable.

  • How Banks Can Safely Handle Payments For Gambling Biz

    Author Photo

    As the betting market continues to expand, it's crucial for banks and fintechs to track historical developments in wagering and ongoing prediction markets litigation that can factor into a risk analysis for payment processing with respect to gambling operators, says Laura D'Angelo at Jones Walker.

  • SEC Focused On Fraud As Actions Markedly Declined In 2025

    Author Photo

    The U.S. Securities and Exchange Commission's enforcement activity in its fiscal year 2025 was its lowest in 10 years, reflecting not only a significant decline in the commission's workforce, but also Chairman Paul Atkins' stated focus on fraud and individual wrongdoing and a new approach to crypto regulation, say attorneys at Covington.

  • Series

    Law School's Missed Lessons: Networking 101

    Author Photo

    Cultivating a network isn't part of the law school curriculum, but learning the soft skills needed to do so may be the key to establishing a solid professional reputation, nurturing client relationships and building business, says Sharon Crane at Practising Law Institute.

  • Defeating Estoppel-Based Claims In Legal Malpractice Actions

    Author Photo

    State supreme court cases from recent years have addressed whether positions taken by attorneys in an underlying lawsuit can be used against them in a subsequent legal malpractice action, providing a foundation to defeat ex-clients’ estoppel claims, says Christopher Blazejewski at Sherin and Lodgen.

  • How Cos. Can Prep For Tightened Calif. Data Breach Notices

    Author Photo

    Amid California's recent enactment of S.B. 446, which significantly amends the state's data breach notification laws, companies should review and update their incident response plans by establishing processes to document and support any delayed notification, and ensure the notifications' accuracy, say Mark Krotoski and Alexandria Marx at Pillsbury.

  • Digital Asset Treasury Trend Signals Wider Crypto Embrace

    Author Photo

    While digital asset treasuries are not new for U.S. public companies, the recent velocity of capital deployment in such investments has been notable, signaling a transformation in corporate treasury management that blurs the lines between traditional finance and the broader crypto ecosystem, say attorneys at DLA Piper.

  • Series

    The Biz Court Digest: How It Works In Massachusetts

    Author Photo

    Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.

  • How The SEC May Overhaul Its Order Protection Rule

    Author Photo

    Attorneys at Skadden trace the evolution of the controversial Rule 611 of Regulation National Market System, examine the current debate surrounding its effectiveness, and consider how the U.S. Securities and Exchange Commission's emerging Project Crypto initiative could reshape Regulation NMS for a tokenized, on-chain market environment.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Securities archive.